Head-to-head · WeighScore
Bliv vs Revel Health
The verdict
Bliv takes it — 66.3/100 to 66.2/100, but only just.
Bliv grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bliv is a telehealth provider selling personalised compounded GLP-1 programmes. Revel Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Bliv | Revel Health |
|---|---|---|
| WeighScore | 66.3/100 | 66.2/100 |
| Grade | C | C |
| Scorecard rank | #187 | #197 |
| Semaglutide | $116/mo (as low as, varies by plan and eligibility, compounded) | $199/mo (compounded) |
| Tirzepatide | $199/mo (as low as, varies by plan and eligibility, compounded) | $249/mo (starting dose, compounded) |
| Coverage | Coverage not published | 45 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #187 · C
Strengths
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Where it loses points
- The advertised rates are 'as low as' figures footnoted 'based on plan structure and eligibility', and the plan selector sits behind the medical intake — the rate you are offered is not knowable before you hand over a medical history
- A $24.99 provider consultation fee is charged on top, and the refund policy deducts $200 for 'clinical coordination and account setup'
- The homepage advertises 'no long-term commitments or cancellation fees' while the terms require the membership fee to be paid 'in a single sum', call it non-refundable and refer to a 'Membership Term'
- The only figure smaller than the advertised rate is a $29 CareCredit/Klarna instalment, which is a financing payment rather than the price of a month of medication
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Graded #197 · C
Strengths
- LegitScript certified with board-certified physicians and USP 795/800 compounding
- Combines GLP-1 weight loss with NAD+, sermorelin and longevity care
- Fast intake — a physician reviews within the hour
- Available in 45 states with a clear list of where it operates
Where it loses points
- Doesn't show upfront pricing — you learn cost during checkout
- Not available in AK, AR, NC, NJ or MS
- Compounded medications only — no brand-name options noted
- Longevity add-ons add cost beyond the core GLP-1 program
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.